Pharmacologic prevention of perinatal HIV infection

NY Rakhmanina; John van den Anker

Pharmacologic prevention of perinatal HIV infection

NY Rakhmanina
, John van den Anker

Neonatal and Pediatric Intensive Care

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Abstract

The goal of antiretroviral therapy for the prevention of mother-to-child transmission (PMTCT) of HIV is to achieve maximal suppression of maternal viral load with minimal maternal, fetal and infant toxicity during pregnancy, delivery and postpartum. In addition to the efficacy and toxicity of antiretroviral therapy, the consideration of HIV resistance in mothers and infected newborns further complicates therapeutic choices for PMTCT. This manuscript summarizes current approaches to PMTC in diverse international settings. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Original language	Undefined/Unknown
Pages (from-to)	S13-S15
Journal	Early Human Development
Volume	90
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MGC-02-53-01-A

Cite this

@article{70051db4e9e14b999a59795a5965e93d,

title = "Pharmacologic prevention of perinatal HIV infection",

abstract = "The goal of antiretroviral therapy for the prevention of mother-to-child transmission (PMTCT) of HIV is to achieve maximal suppression of maternal viral load with minimal maternal, fetal and infant toxicity during pregnancy, delivery and postpartum. In addition to the efficacy and toxicity of antiretroviral therapy, the consideration of HIV resistance in mothers and infected newborns further complicates therapeutic choices for PMTCT. This manuscript summarizes current approaches to PMTC in diverse international settings. (C) 2014 Elsevier Ireland Ltd. All rights reserved.",

author = "NY Rakhmanina and \{van den Anker\}, John",

year = "2014",

language = "Undefined/Unknown",

volume = "90",

pages = "S13--S15",

journal = "Early Human Development",

issn = "0378-3782",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Pharmacologic prevention of perinatal HIV infection

AU - Rakhmanina, NY

AU - van den Anker, John

PY - 2014

Y1 - 2014

N2 - The goal of antiretroviral therapy for the prevention of mother-to-child transmission (PMTCT) of HIV is to achieve maximal suppression of maternal viral load with minimal maternal, fetal and infant toxicity during pregnancy, delivery and postpartum. In addition to the efficacy and toxicity of antiretroviral therapy, the consideration of HIV resistance in mothers and infected newborns further complicates therapeutic choices for PMTCT. This manuscript summarizes current approaches to PMTC in diverse international settings. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

AB - The goal of antiretroviral therapy for the prevention of mother-to-child transmission (PMTCT) of HIV is to achieve maximal suppression of maternal viral load with minimal maternal, fetal and infant toxicity during pregnancy, delivery and postpartum. In addition to the efficacy and toxicity of antiretroviral therapy, the consideration of HIV resistance in mothers and infected newborns further complicates therapeutic choices for PMTCT. This manuscript summarizes current approaches to PMTC in diverse international settings. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

M3 - Article

SN - 0378-3782

VL - 90

SP - S13-S15

JO - Early Human Development

JF - Early Human Development

ER -